Isolated tumor rejection antigens derived from DAGE tumor rejection antigen precusor
First Claim
Patent Images
1. Isolated peptide selected from the group consisting of (i) the peptide whose amino acid sequence consists of SEQ ID NO:
- 5, and (ii) the peptide where amino acid sequence consists of SEQ ID NO;
6.
2 Assignments
0 Petitions
Accused Products
Abstract
A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as DAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as GAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigens, and their precursor molecules are described.
3 Citations
3 Claims
-
1. Isolated peptide selected from the group consisting of (i) the peptide whose amino acid sequence consists of SEQ ID NO:
- 5, and (ii) the peptide where amino acid sequence consists of SEQ ID NO;
6. - View Dependent Claims (2, 3)
- 5, and (ii) the peptide where amino acid sequence consists of SEQ ID NO;
Specification